Health
Pfizer-BioNTech COVID-19 Vaccine Achieves 100% Effectiveness in Adolescents – Contagionlive.com
The newest data for the real-world assessment show the mRNA vaccine provides greater immunogenicity in persons aged 12-15 years old than in young adults.
Pfizer-BioNTech COVID-19 vaccine BNT162b2 provided an observed vaccine efficacy of 100% among adolescents aged 12-15 years old after 7 days post-administration with the 2-dose product.
The new findings from an ongoing, placebo-controlled, observer-blinded assessment of the mRNA vaccine in adolescent patients suggest BNT162b2 provides an even greater immune response in the population than that observed in vaccinated young adults.
Led by Robert W. Frenck, Jr., MD, of the Cincinnati Childrens Hospital,…
-
Noosa News19 hours agoFamily pleads for help after 17-year-old Pheobe Bishop disappears in Bundaberg before flight
-
Business20 hours agoASX 200 lifts on the RBA’s latest interest rate call
-
Noosa News23 hours agoNo conviction recorded for teen behind attack on Peter Dutton’s office
-
Noosa News23 hours ago‘They’re not taking the concerns of women seriously’